CN1559494A - 一种治疗咽喉疾病的药物 - Google Patents
一种治疗咽喉疾病的药物 Download PDFInfo
- Publication number
- CN1559494A CN1559494A CNA2004100107081A CN200410010708A CN1559494A CN 1559494 A CN1559494 A CN 1559494A CN A2004100107081 A CNA2004100107081 A CN A2004100107081A CN 200410010708 A CN200410010708 A CN 200410010708A CN 1559494 A CN1559494 A CN 1559494A
- Authority
- CN
- China
- Prior art keywords
- fructus momordicae
- yanhou pian
- medicine
- group
- yanhou
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 201000010099 disease Diseases 0.000 title claims description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims description 21
- 229940079593 drug Drugs 0.000 title description 19
- 241000628997 Flos Species 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 3
- 230000001684 chronic effect Effects 0.000 abstract description 5
- 230000001154 acute effect Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 235000015489 Emblica officinalis Nutrition 0.000 abstract 1
- 241001530126 Scrophularia Species 0.000 abstract 1
- 244000277583 Terminalia catappa Species 0.000 abstract 1
- 235000011517 Terminalia chebula Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 27
- 201000007100 Pharyngitis Diseases 0.000 description 18
- 241000699670 Mus sp. Species 0.000 description 15
- 210000003800 pharynx Anatomy 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 12
- 230000001629 suppression Effects 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 206010068319 Oropharyngeal pain Diseases 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 230000036760 body temperature Effects 0.000 description 6
- 239000003172 expectorant agent Substances 0.000 description 6
- 230000003419 expectorant effect Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 210000000265 leukocyte Anatomy 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 206010018691 Granuloma Diseases 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000012109 statistical procedure Methods 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 206010024796 Logorrhoea Diseases 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 229920001525 carrageenan Polymers 0.000 description 4
- 235000010418 carrageenan Nutrition 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000001541 thymus gland Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010006784 Burning sensation Diseases 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 240000001307 Myosotis scorpioides Species 0.000 description 3
- 206010067482 No adverse event Diseases 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 208000037976 chronic inflammation Diseases 0.000 description 3
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- 208000030090 Acute Disease Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 244000132059 Carica parviflora Species 0.000 description 2
- 235000014653 Carica parviflora Nutrition 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 241000192041 Micrococcus Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 229940046011 buccal tablet Drugs 0.000 description 2
- 239000006189 buccal tablet Substances 0.000 description 2
- 230000004856 capillary permeability Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 201000002882 Agraphia Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- -1 dry below 60 °C Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000009438 liyan Substances 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410010708 CN1220515C (zh) | 2004-02-22 | 2004-02-22 | 一种治疗咽喉疾病的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410010708 CN1220515C (zh) | 2004-02-22 | 2004-02-22 | 一种治疗咽喉疾病的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1559494A true CN1559494A (zh) | 2005-01-05 |
CN1220515C CN1220515C (zh) | 2005-09-28 |
Family
ID=34440006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410010708 Expired - Fee Related CN1220515C (zh) | 2004-02-22 | 2004-02-22 | 一种治疗咽喉疾病的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1220515C (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101411782B (zh) * | 2008-11-11 | 2011-06-08 | 南京同仁堂药业有限责任公司 | 一种治疗急性咽炎的药物组合物及其制备方法 |
CN101856424B (zh) * | 2009-09-03 | 2011-10-05 | 张钦 | 治疗慢性咽炎病的中药 |
CN115227624A (zh) * | 2022-08-30 | 2022-10-25 | 北京臻味坊食品有限公司 | 含坚果油的婴儿护肤油 |
-
2004
- 2004-02-22 CN CN 200410010708 patent/CN1220515C/zh not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101411782B (zh) * | 2008-11-11 | 2011-06-08 | 南京同仁堂药业有限责任公司 | 一种治疗急性咽炎的药物组合物及其制备方法 |
CN101856424B (zh) * | 2009-09-03 | 2011-10-05 | 张钦 | 治疗慢性咽炎病的中药 |
CN115227624A (zh) * | 2022-08-30 | 2022-10-25 | 北京臻味坊食品有限公司 | 含坚果油的婴儿护肤油 |
CN115227624B (zh) * | 2022-08-30 | 2023-11-14 | 北京臻味坊食品有限公司 | 含坚果油的婴儿护肤油 |
Also Published As
Publication number | Publication date |
---|---|
CN1220515C (zh) | 2005-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1207033C (zh) | 一种治疗风热感冒的中药组合物及其制备方法 | |
CN1947754A (zh) | 一种治疗小儿哮喘的药物及其制备方法 | |
CN1456344A (zh) | 一种治疗咽喉炎的药物组合物及其制备方法 | |
CN1225252C (zh) | 用于预防和治疗关节炎的包含药用草本提取物的组合物的制备方法及所述的组合物 | |
CN1857362A (zh) | 金感康药物制剂及其制备方法 | |
CN1220515C (zh) | 一种治疗咽喉疾病的药物 | |
CN1903254A (zh) | 治疗风热感冒的复方药物及其制备方法 | |
CN1304735A (zh) | 一种治疗慢性结肠炎的药物 | |
CN1197612C (zh) | 治疗泌尿系统结石和尿路感染疾病的中药制剂及其制备方法 | |
CN1056298C (zh) | 一种治疗软组织损伤的外用药及其生产方法 | |
CN100337658C (zh) | 治疗感冒风热症的中药组合物及其制备方法 | |
CN1290529C (zh) | 治疗痛风、高尿酸血症和高脂血症的药物及其制备方法 | |
CN1814221A (zh) | 一种治疗尿路感染的中药组合物及其制备方法 | |
CN1899523A (zh) | 一种治疗急、慢性咽喉炎的中药组合物及其制备方法 | |
CN1460492A (zh) | 治疗急慢性鼻炎的中药制剂及其生产方法 | |
CN1650903A (zh) | 从天然植物中药有效成分中提取清音利嗓制品药物的方法 | |
CN1555851A (zh) | 一种具有清肺功能的组合物及其制备方法 | |
CN1589892A (zh) | 一种治疗急、慢性咽炎的药物组合物及其制备方法 | |
CN1602945A (zh) | 通窍鼻炎软胶囊及其制备工艺 | |
CN1840008A (zh) | 一种能清咽润喉的中药颗粒及其制备方法 | |
CN101062314A (zh) | 一种治疗痛风的药物及其制备方法 | |
CN1239199C (zh) | 一种治疗胃炎、消化性溃疡的药物及其制备方法 | |
CN1679692A (zh) | 一种治疗淋病的药物及其制备方法 | |
CN1660399A (zh) | 一种治疗风寒湿痹及筋骨萎软的药物 | |
CN1296822A (zh) | 一种治疗肺结核病的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right |
Effective date of registration: 20051220 Pledge (preservation): Preservation |
|
PD01 | Discharge of preservation of patent |
Date of registration: 20060620 Pledge (preservation): Preservation |
|
PP01 | Preservation of patent right |
Effective date of registration: 20061214 Pledge (preservation): Preservation |
|
PD01 | Discharge of preservation of patent |
Date of cancellation: 20071214 Pledge (preservation): Preservation registration |
|
ASS | Succession or assignment of patent right |
Owner name: TONGHUA ZHONGSHENG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: FANGDA PHARMACEUTICAL CO LTD, TONGHUA CITY Effective date: 20150721 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150721 Address after: Jiang Road 130010 Tonghua city of Jilin Province Dongchang District No. 900 Patentee after: Tonghua Zhongsheng Pharmaceutical Co.,Ltd. Address before: Jiang Road 134000 Tonghua city of Jilin Province Dongchang District No. 50 Patentee before: Tonghua Fangda Pharmaceutical Co.,Ltd. |
|
PP01 | Preservation of patent right |
Effective date of registration: 20180601 Granted publication date: 20050928 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20240222 Granted publication date: 20050928 |
|
PD01 | Discharge of preservation of patent | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050928 |
|
CF01 | Termination of patent right due to non-payment of annual fee |